Privi Speci. Q1 FY27 Results (NSE: PRIVISCL)
Signal: Margin expansion
The read
14th straight quarter of YoY margin expansion (OPM +400bps to 24%), driven by operating leverage as employee/other costs grew far slower than revenue. Revenue growth of 20.5% YoY is healthy though sequentially softer (Q4 typically higher). PAT was boosted by a 39% drop in finance cost. The Scheme of Amalgamation for two subsidiaries is pending NCLT approval – no current impact.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹559.36 Cr | 20.5% | -22.7% |
| EBIT | ₹136.41 Cr | 77.0% | |
| Net profit | ₹57.8 Cr | 97.5% | |
| EPS | ₹15.84 | 97.5% | |
| EBIT margin | 24% |
P&L walk
Revenue grew 20.5% YoY to ₹55,936 lakh; OPM expanded 400bps to 24% on operating leverage; EBITDA grew 77% YoY vs revenue growth of 20.5%, employee cost up only 11.2% and other expenses +7.6% vs revenue +20.5%; PAT at ₹5,780 lakh, +97.5% YoY, boosted by lower finance cost (down 39%) and higher other income.
Segments
Single operating segment – Aroma Chemical. No segment split.
Key positives
- OPM expanded 400bps YoY to 24% – 14th consecutive quarter of margin expansion.
- Employee cost grew only 11.2% YoY, other expenses +7.6% YoY, both far below revenue growth of 20.5%, demonstrating operating leverage.
- Finance cost declined 39% YoY to ₹1,642 lakh, improving bottom-line flow-through.
Key concerns
- Sequential revenue fell 22.7% vs Q4FY26 (₹72,157 lakh), partly normal seasonality post a strong Q4.
- Depreciation fell 11.7% YoY – possible if asset base is declining, but no balance sheet to confirm.
Research and educational content only. Not investment advice.